↓ Skip to main content

Dove Medical Press

Biosimilars in Pediatric IBD: Updated Considerations for Disease Management

Overview of attention for article published in Biologics: Targets & Therapy, June 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#34 of 284)
  • High Attention Score compared to outputs of the same age (84th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news
1 news outlet
twitter
3 X users

Readers on

mendeley
11 Mendeley
Title
Biosimilars in Pediatric IBD: Updated Considerations for Disease Management
Published in
Biologics: Targets & Therapy, June 2022
DOI 10.2147/btt.s367032
Pubmed ID
Authors

Valeria Dipasquale, Ugo Cucinotta, Claudio Romano

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 18%
Other 2 18%
Student > Doctoral Student 2 18%
Student > Master 1 9%
Unknown 4 36%
Readers by discipline Count As %
Medicine and Dentistry 3 27%
Unspecified 2 18%
Agricultural and Biological Sciences 1 9%
Chemical Engineering 1 9%
Unknown 4 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 January 2023.
All research outputs
#3,116,345
of 25,392,582 outputs
Outputs from Biologics: Targets & Therapy
#34
of 284 outputs
Outputs of similar age
#66,936
of 446,492 outputs
Outputs of similar age from Biologics: Targets & Therapy
#1
of 5 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 284 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,492 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them